This site is intended for Healthcare professionals only.

Ajanta Pharma Announces Launch of Omeprazole and Sodium Bicarbonate Powder for Oral Suspension


Ajanta Pharma Announces Launch of Omeprazole and Sodium Bicarbonate Powder for Oral Suspension

Ajanta Pharma USA Inc., a wholly owned subsidiary of Ajanta Pharma Ltd, announces the launch of Omeprazole and Sodium Bicarbonate Powder for Oral Suspension, a bioequivalent prescription generic version of Zegerid® Powder for Oral Suspension (20mg/1680mg and 40mg/1680mg), into the US market.

Omeprazole and Sodium Bicarbonate Powder for Oral Suspension is part of an ever-growing portfolio of products that Ajanta has developed for the US market. In total, Ajanta has 26 Abbreviated New Drug Applications (ANDAs) of which it has 14 final ANDA approvals; 2 tentative approvals; and 10 ANDAs under review with the United States Food & Drug Administration.



Source: Press Release
0 comment(s) on Ajanta Pharma Announces Launch of Omeprazole and Sodium Bicarbonate Powder for Oral Suspension

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted